India moves to beef up pharma sector, clinical trial oversight

06/30/2013 | Economic Times (India), The

The Central Drugs Standard Control Organization, the U.S. FDA's counterpart in India, hopes to better regulate the pharma sector with a tenfold increase of its drug inspection staff. The agency also intends to bolster state-level regulatory bodies and create eight additional central research facilities to address the rising number of clinical studies in the country.

View Full Article in:

Economic Times (India), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA